The prediction of metabolic activities in silico form is crucial to be able to address all research possibilities without exceeding the experimental costs. In particular, for cancer research, the prediction of certain activities can be of great help in the discovery of different treatments. In this work it has been proposed to predict, through Machine Learning, the anti-angiogenic activity of peptides is currently being used in cancer treatment and is giving hopeful results. From a list of peptide sequences, three types of molecular descriptors were obtained (AAC, DC and TC) that offered the possibility of training different ML algorithms. After a Feature Selection process, different models were obtained with a predictive value that surpassed the current state of the art. These results shown that ML is useful for the classification and prediction of the activity of new peptides, making experimental screening cheaper and faster.